Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Clazakizumab by CSL for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD): Likelihood of Approval
Clazakizumab is under clinical development by CSL and currently in Phase III for End-Stage Kidney Disease (End-Stage Renal Disease or...
Data Insights
Clazakizumab by CSL for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Clazakizumab is under clinical development by CSL and currently in Phase II for Coronavirus Disease 2019 (COVID-19). According to GlobalData,...